although
sever
report
suggest
entri
infecti
bronchiti
viru
ibv
depend
lipid
raft
low
ph
endocyt
rout
intracellular
traffick
unclear
studi
aim
shed
greater
light
earli
step
ibv
infect
use
chemic
inhibitor
rna
interfer
domin
neg
mutant
observ
lipid
raft
low
ph
inde
requir
viru
entri
ibv
mainli
util
clathrin
mediat
endocytosi
cme
entri
gtpase
dynamin
involv
viru
contain
vesicl
scission
penetr
ibv
cell
led
activ
cytoskeleton
rearrang
use
label
viru
found
viru
particl
move
along
classic
endosomelysosom
track
function
inactiv
significantli
inhibit
ibv
infect
final
use
dual
label
ibv
observ
membran
fusion
induc
hpi
late
endosomelysosom
virus
take
advantag
cellular
endocyt
pathway
enter
host
cell
cossart
heleniu
yamauchi
heleniu
intern
viru
particl
move
dynam
network
endocyt
vesicl
undergo
gradual
sort
complex
matur
event
endosom
matur
turn
trigger
conform
chang
dissoci
event
incom
virus
ultim
lead
deliveri
viral
genom
associ
protein
cytoplasm
gener
nonenvelop
virus
abl
penetr
plasma
membran
endosom
membran
pore
format
lysi
suomalainen
greber
envelop
virus
usual
fuse
vesicl
membran
releas
genom
cytoplasm
harrison
numer
viru
famili
util
endocytosi
infect
host
cell
mediat
viru
intern
well
traffick
site
replic
differ
virus
employ
variou
rout
endocytosi
rout
taken
given
viru
larg
depend
receptor
viru
interact
endocyt
pathway
util
virus
includ
clathrinmedi
endocytosi
cme
caveolinraftmedi
endocytosi
cavm
macropinocytosi
nonclathrinnoncaveolin
mediat
endocytosi
among
cme
best
understood
endocyt
pathway
respons
receptor
mediat
intern
signal
clathrin
recruit
plasma
membran
lead
assembl
clathrinco
pit
ccp
cytoplasm
side
plasma
membran
main
scaffold
compon
clathrin
coat
clathrin
heavi
chain
chc
clathrin
light
chain
clc
form
threeleg
trimer
call
triskelion
keen
adapt
protein
provid
bridg
receptor
cargo
domain
clathrin
subunit
kirchhausen
assembl
ccp
pinch
plasma
membran
matur
clathrinco
vesicl
keen
help
dynamin
gtpase
lot
virus
use
cme
enter
cell
includ
semliki
forest
viru
vonderheit
heleniu
vesicular
stomat
viru
vsv
cureton
et
al
hepat
c
viru
benedicto
et
al
adenoviru
meier
et
al
caveola
rel
small
vesicl
diamet
nm
flaskshap
invas
form
membran
retract
plasma
membran
special
lipid
raft
domain
compos
caveolin
high
level
cholesterol
hommelgaard
et
al
insel
viru
pelkman
et
al
virus
includ
picornavirus
marjomaki
et
al
papillomavirus
bousarghin
et
al
filovirus
empig
goldsmith
murin
leukemia
viru
beer
et
al
human
coronaviru
nomura
et
al
classic
swine
fever
viru
zhang
et
al
found
util
cavm
enter
cell
macropinocytosi
morpholog
defin
presenc
membran
extens
outwardli
polymer
actin
term
membran
ruffl
identifi
entri
mechan
sever
pathogen
includ
adenoviru
kalin
et
al
coxsacki
b
viru
inal
jorfi
influenza
viru
de
vri
et
al
ebola
viru
aleksandrowicz
et
al
vaccinia
viru
rizopoulo
et
al
nipah
viru
vogt
et
al
kaposi
sarcomaassoci
herpesviru
raghu
et
al
newcastl
diseas
viru
tan
et
al
lipid
raft
function
membran
microdomain
also
term
detergentinsolubl
glycolipidenrich
complex
detergentresist
membran
rich
protein
fivaz
et
al
simon
ikonen
serv
domain
concentr
membraneassoci
protein
includ
receptor
signal
molecul
simon
ikonen
addit
physiolog
role
signal
transduct
host
cell
simon
toomr
lipid
raft
often
serv
site
entri
assembl
bud
microbi
pathogen
kovbasnjuk
et
al
rawat
et
al
suomalainen
involv
bind
entri
host
cell
sever
envelop
nonenvelop
virus
includ
human
immunodefici
viru
type
viard
et
al
polioviru
danthi
chow
human
herp
viru
huang
et
al
west
nile
viru
medigeshi
et
al
footandmouth
diseas
viru
martinaceb
et
al
dengu
viru
diwak
et
al
evid
lipid
raft
also
involv
coronaviru
entri
case
viru
entri
inhibit
deplet
cholesterol
result
disrupt
viral
associ
cellular
receptor
nomura
et
al
thorp
gallagh
show
lipid
raft
crucial
entri
mous
hepat
viru
mhv
thorp
gallagh
moreov
guo
et
al
demonstr
lipid
raft
involv
ibv
entri
guo
et
al
coronavirus
envelop
plusstrand
rna
virus
belong
famili
coronavirida
includ
mani
human
anim
pathogen
global
concern
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
viru
merscov
mhv
porcin
epidem
diarrhea
viru
pedv
felin
infecti
periton
viru
fipv
ibv
case
caus
respiratori
andor
intestin
tract
diseas
gener
coronavirus
enter
cell
endocytosi
undergo
phdepend
membran
fusion
exampl
cme
well
clathrinand
caveolaeindepend
entri
pathway
report
sarscov
inou
et
al
wang
et
al
clathrinand
serin
proteasesdepend
uptak
report
pedv
park
et
al
fipv
suggest
enter
cell
via
clathrinand
caveolaeindepend
endocyt
rout
van
hamm
et
al
enter
cell
via
cme
independ
pu
zhang
ibv
belong
genu
gamma
coronaviru
genom
approxim
kilobas
kb
length
encod
polyprotein
four
structur
protein
name
spike
protein
membran
protein
small
envelop
protein
e
nucleocapsid
protein
n
four
accessori
protein
name
polyprotein
cleav
viral
proteas
least
nonstructur
protein
despit
import
ibv
one
domin
pathogen
caus
highli
contagi
infecti
bronchiti
worldwid
lead
signific
econom
loss
chicken
industri
littl
inform
avail
entri
mechan
suggest
entri
ibv
cell
depend
lipid
raft
low
ph
chu
et
al
howev
endocyt
pathway
ibv
hijack
unclear
earli
step
entri
process
ibv
target
cell
initi
engag
glycoprotein
receptor
use
sever
cell
line
permiss
ibv
beaudett
strain
report
ibv
virion
attach
lipid
raft
cell
surfac
effici
entri
ibv
cell
requir
presenc
intact
lipid
raft
also
address
ibv
entri
pathway
systemat
perturb
function
key
factor
variou
endocyt
rout
use
chemic
inhibitor
sirna
silenc
overexpress
domin
neg
dn
protein
achiev
success
track
virion
attach
entri
intracellular
traffick
membran
fusion
octadecyl
rhodamin
iodid
dioc
label
viral
membran
fluoresc
tag
immunofluoresc
analysi
use
visual
coloc
cotraffick
viru
cellular
factor
result
reveal
ibv
intern
cell
cme
transport
along
earli
endosom
late
endosom
fuse
membran
late
endosomelysosom
vero
cell
cell
cell
maintain
dulbecco
modifi
eagl
medium
dmem
mgl
glucos
supplement
fetal
bovin
serum
fb
hyclon
usa
unitsml
penicillin
streptomycin
invitrogen
usa
cell
maintain
roswel
park
memori
institut
rpmi
supplement
fb
presenc
unit
ml
penicillin
streptomycin
cell
purchas
atcc
usa
cultur
co
beaudett
strain
ibv
atcc
adapt
vero
cell
use
studi
well
character
viru
vesicular
stomat
viru
vsv
use
control
viru
studi
viru
stock
prepar
infect
monolay
vero
cell
multipl
infect
moi
fb
free
dmem
attach
h
unbound
viru
remov
replac
fb
free
dmem
viru
cell
incub
cell
cytopath
effect
cpe
freez
thaw
viru
contain
cell
medium
three
time
cell
debri
remov
centrifug
supernat
aliquot
store
viru
stock
control
vero
cell
lysat
mockinfect
cell
prepar
manner
viru
yield
assess
tissu
cultur
infect
dose
tcid
titrat
supernat
ibvinfect
cell
collect
centrifug
min
remov
cell
debri
viral
titer
determin
tcid
assay
briefli
serial
dilut
aliquot
viru
appli
confluent
monolay
vero
cell
plate
h
absorpt
unbound
virus
remov
cell
wash
twice
dmem
plate
incub
dmem
cytopath
effect
cpe
observ
day
sampl
titrat
triplic
tcid
calcul
use
reed
munch
mathemat
analysi
mchenri
et
al
vero
cell
infect
virus
moi
incub
cell
cpe
cultur
medium
viru
particl
clarifi
centrifug
min
supernat
centrifug
min
concentr
use
centrifug
filter
devic
cutoff
merk
poland
provid
fast
ultrafiltr
mock
infect
vero
cell
cultur
medium
concentr
manner
control
sampl
label
prepar
describ
previous
chu
et
al
concentr
viru
control
sampl
incub
mm
molecular
probe
usa
rotari
shaker
h
room
temperatur
label
prepar
describ
krzyzaniak
et
al
concentr
viru
control
sampl
incub
mm
dioc
molecular
probe
usa
mm
mixtur
molecular
probe
usa
gentl
shake
h
room
temperatur
finish
label
viru
dye
mixtur
resuspend
ml
phosphatebuff
salin
pb
excess
dye
remov
centrifug
filter
devic
cutoff
merk
poland
centrifug
min
final
label
viru
label
mock
sampl
obtain
endocytot
pathway
inhibitor
amilorid
nystatin
chlorpromazin
cpz
purchas
selleck
usa
actin
monomersequest
drug
cytochalasin
cytod
actin
polymerstabil
jasplakinolid
ja
purchas
thermo
fisher
scientif
usa
endosom
acidif
inhibitor
nh
cl
cholesterol
deplet
drug
cholesterolwat
solubl
purchas
sigmaaldrich
usa
antiibv
n
antibodi
obtain
immun
rabbit
respect
antigen
gener
gift
prof
liu
dingxiang
lab
south
china
agricultur
univers
china
antigfp
antichc
clathrin
heavi
chain
purchas
cell
signal
technolog
usa
antivsv
g
obtain
abcam
uk
purchas
sigma
aldrich
usa
cholera
toxin
subunit
b
ctb
purchas
thermo
fisher
scientif
usa
fluorescein
isothiocyan
fitc
conjug
antimous
antirabbit
immunoglobulin
g
igg
well
horseradish
peroxidas
hrp
conjug
antimous
antirabbit
igg
purchas
cell
signal
technolog
usa
alexa
fluor
phalloidin
purchas
thermo
fisher
usa
examin
effect
variou
inhibitor
ibv
infect
vero
cell
cell
cell
cell
cell
seed
plate
cellswel
cultur
h
reach
confluenc
cell
pretreat
indic
concentr
nh
cl
cpz
nystatin
amilorid
ja
cytod
min
respect
treatment
cell
inocul
ibv
vsv
moi
incub
h
presenc
correspond
compound
unbound
virion
wash
away
pb
cell
incub
fresh
medium
without
compound
addit
h
h
viru
intern
determin
semiquantit
real
time
rtpcr
hpi
measur
viral
rna
genom
viru
replic
monitor
western
blot
hpi
check
express
level
viral
protein
viabil
drugtreat
cell
measur
use
cell
prolifer
cytotox
assay
kit
accord
manufactur
instruct
beyotim
haimen
china
cell
seed
plate
treat
indic
drug
ad
well
incub
h
absorb
nm
monitor
refer
wavelength
set
nm
viabil
cell
calcul
comparison
untreat
cell
assess
effect
nh
cl
ph
chang
acid
intracellular
vesicl
vero
cell
treat
increas
concentr
nh
cl
min
follow
mgml
acridin
orang
sigma
stain
serum
free
medium
min
cell
wash
twice
pb
stain
dapi
dihydrochlorid
roch
imag
taken
zeiss
axio
observ
fluoresc
microscop
cell
incub
mm
min
indic
infect
time
cours
cell
expos
dmso
min
set
control
group
incub
cell
wash
twice
pb
replac
fresh
cultur
medium
cholesterol
replenish
cell
pretreat
mm
min
supplement
exogen
mm
cholesterol
incub
h
extens
wash
pb
cell
infect
ibv
cell
incub
ibv
moi
h
mockinfect
cell
set
control
group
cell
lyse
ice
min
ml
tne
lysi
buffer
triton
supplement
complet
proteas
inhibitor
cocktail
cell
lysat
centrifug
min
remov
cell
debri
nuclei
supernat
collect
mix
ml
tne
buffer
sucros
place
bottom
ultracentrifug
tube
overlaid
ml
ml
sucros
tne
buffer
lysat
ultracentrifug
h
rotor
beckman
centrifug
fraction
ml
collect
top
bottom
tube
subject
follow
western
blot
use
antibodi
antin
protein
anti
protein
cell
grown
plate
transfect
plasmid
dna
use
lipofectamin
invitrogen
accord
manufactur
instruct
h
posttransfect
cell
infect
viru
moi
knock
dynamin
small
interf
rna
sirna
duplex
concentr
nm
transfect
cell
use
lipofectamin
h
posttransfect
cell
infect
viru
moi
level
ibv
intern
viral
protein
express
viru
particl
releas
measur
semiquantit
real
time
rtpcr
western
blot
analysi
tcid
indic
time
point
sirna
sequenc
shown
tabl
viral
intern
detect
describ
previous
zhu
et
al
briefli
cell
plate
incub
ibv
h
unbound
virion
wash
away
pb
cell
incub
fresh
medium
hpi
cell
treat
mgml
proteinas
k
invitrogen
min
remov
adsorb
intern
viru
proteinas
k
inactiv
mm
phenylmethylsulfonyl
fluorid
pmsf
pb
bovin
serum
albumin
cell
wash
three
time
pb
lyse
ml
trizol
reagent
invitrogen
usa
per
well
rna
isol
one
fifth
volum
chloroform
ad
cell
lysat
mixtur
centrifug
min
aqueou
phase
mix
equal
volum
isopropanol
incub
min
rna
precipit
centrifug
min
rna
pellet
wash
rnasefre
ethanol
dissolv
rnasefre
water
level
intern
viral
grna
grna
determin
real
time
rtpcr
briefli
total
rna
use
perform
revers
transcript
use
expand
revers
transcriptas
roch
usa
oligodt
ibv
specif
primer
equal
volum
cdna
pcramplifi
use
sybr
green
pcr
master
kit
dongsheng
biotech
guangdong
china
genom
copi
number
normal
level
use
compar
cycl
threshold
valu
determin
parallel
experi
data
analyz
rel
control
assay
perform
three
replic
primer
sequenc
use
rtpcr
shown
tabl
cell
lyse
sd
load
buffer
presenc
mm
dithiothreitol
denatur
min
equival
amount
protein
separ
sdspage
follow
transfer
onto
polyvinylidenedifluorid
pvdf
membran
biorad
laboratori
usa
electroblot
immunoblot
analysi
perform
incub
membran
block
buffer
h
room
temperatur
appropri
antibodi
dilut
block
buffer
anoth
h
wash
three
time
pbst
membran
incub
hrpconjug
secondari
antibodi
h
wash
pbst
thrice
blot
develop
enhanc
chemiluminesc
ecl
detect
system
ge
healthcar
life
scienc
usa
expos
chemiluminesc
gel
imag
system
tanon
shanghai
china
membran
strip
strip
buffer
mm
sd
mm
triscl
ph
min
reprob
antibodi
cell
seed
chamber
slide
infect
viru
label
viru
moi
indic
time
point
cell
fix
paraformaldehyd
min
wash
thrice
pb
permeabil
triton
min
wash
thrice
pb
cell
block
fb
h
incub
dilut
pb
bsa
wash
thrice
pb
incub
secondari
antibodi
conjug
fitc
dako
h
dilut
pb
bsa
follow
pb
wash
detect
ctbfitc
cell
permeabil
requir
cell
incub
ctbfitc
h
actin
stain
fix
permeabil
cell
incub
alexa
fluor
phalloidin
h
cell
incub
dapi
min
rins
pb
final
specimen
mount
glass
cover
slip
use
fluoresc
mount
medium
dako
contain
imag
collect
confoc
laserscan
microscop
zeiss
amplifi
pcr
hela
cellular
cdna
clone
vector
restrict
enzym
xho
bamh
control
cytomegaloviru
promot
gener
egfptag
nterminu
egfptag
mutant
construct
sitedirect
overlap
two
round
pcr
mutagenesi
egfptag
construct
describ
previous
rizopoulo
et
al
use
takara
mutant
best
kit
takara
bio
dalian
china
construct
gener
gift
prof
mao
xiang
primer
use
plasmid
construct
shown
tabl
data
present
mean
standard
deviat
sd
indic
student
ttest
use
compar
data
pair
treat
untreat
group
statist
signific
indic
figur
legend
statist
analys
calcul
perform
use
graph
pad
prism
graph
pad
softwar
inc
la
jolla
ca
intens
correspond
band
quantifi
use
imag
j
program
nih
accord
manufactur
instruct
lipid
raft
cholesterolenrich
microdomain
mani
cellular
protein
includ
viral
receptor
preferenti
local
number
virus
enter
host
cell
lipid
raft
fivaz
et
al
previou
report
show
ibv
structur
protein
migrat
integr
lipid
raft
infect
nonstructur
protein
integr
raft
guo
et
al
suggest
lipid
raft
might
particip
ibv
entri
buddingreleas
examin
stage
infect
lipid
raft
involv
use
disrupt
lipid
raft
differ
stage
infect
ibv
beaudett
strain
permiss
cell
line
subtox
dose
determin
cell
prolifer
assay
supplementari
fig
determin
subtox
dose
ibv
permiss
vero
cell
treat
mm
min
pre
postibv
infect
hpi
fig
effect
viru
infect
access
check
viral
grna
viral
protein
progeni
viru
releas
respect
shown
fig
treatment
variou
cell
line
hpi
acquir
maximum
blockag
viru
genom
product
determin
check
viral
grna
hpi
surprisingli
treatment
hpi
affect
viru
genom
product
consist
treatment
hpi
obtain
maximum
inhibit
effect
viral
n
protein
express
wherea
treatment
postentri
step
affect
viral
protein
express
consequ
progeni
viru
product
decreas
tabl
primer
sequenc
semiquantit
real
time
rtpcr
primer
sequenc
treatment
hpi
postentri
treatment
data
demonstr
inhibit
viru
entri
step
postentri
process
suggest
intact
lipid
raft
requir
viru
entri
check
whether
effect
viru
entri
sole
due
cholesterol
deplet
examin
effect
exogen
cholesterol
replenish
viru
entri
treatment
vero
cell
pretreat
mm
supplement
exogen
mm
cholesterol
follow
ibv
infect
result
fig
c
show
treatment
reduc
viru
grna
intern
howev
cholesterol
replenish
restor
viru
grna
uptak
accordingli
viral
n
protein
express
reduc
treatment
restor
cholesterol
replenish
accord
progeni
viru
rescu
cholesterol
replenish
result
demonstr
ibv
entri
depend
intact
lipid
raft
variou
permiss
cell
line
mention
receptor
ibv
entri
controversi
wherea
work
state
heparan
sulfat
select
attach
factor
ibv
beaudett
strain
madu
et
al
anoth
report
suggest
sialic
acid
receptor
determin
infect
winter
et
al
sinc
membran
cholesterol
play
import
role
earli
infect
stage
interact
ibv
receptor
may
occur
lipid
raft
test
hypothesi
vero
cell
incub
ibv
moi
h
lipid
raft
isol
sucros
flotat
gradient
individu
fraction
analyz
presenc
lipid
raft
marker
flotillin
ibv
n
protein
ibv
protein
western
blot
ibvinfect
cell
found
protein
n
protein
coloc
raft
marker
flotillin
fraction
fig
right
panel
thu
biochem
fraction
analysi
suggest
associ
ibv
lipid
raft
attach
step
directli
observ
bind
viru
particl
cell
surfac
lipid
raft
ibv
label
lipophil
fluoresc
dye
produc
cell
cultur
medium
without
viru
infect
concentr
mix
control
group
elimin
possibl
misstain
cell
compon
retain
moder
level
infect
compar
intact
ibv
determin
western
blot
fig
immunofluores
perform
check
interact
lipid
raft
marker
vero
cell
incub
either
h
follow
ctbfitc
bind
lipid
raft
marker
stain
shown
fig
red
signal
treat
cell
infect
cell
display
red
dot
signal
plasma
membran
suggest
red
dot
signal
inde
repres
ibv
virion
addit
red
signal
coloc
ctbfitc
mark
outlin
lipid
raft
result
confirm
associ
ibv
lipid
raft
cell
surfac
attach
step
although
previou
studi
demonstr
entri
ibv
beaudett
strain
sensit
ph
increas
bhk
cell
chu
et
al
also
suggest
viru
may
employ
differ
entri
rout
differ
cell
type
frana
et
al
thu
necessari
verifi
whether
low
ph
depend
entri
ibv
cell
type
specif
subtox
dose
endosom
acidif
inhibitor
nh
cl
determin
cell
viabil
assay
show
vero
cell
toler
treatment
nh
cl
mm
supplementari
fig
increas
ph
intracellular
vesicl
confirm
acridin
orang
stain
untreat
cell
typic
orang
fluoresc
indic
acid
compart
expect
orang
fluoresc
quench
along
increas
concentr
nh
cl
supplementari
fig
basic
mechan
phdepend
endocytosi
vsv
well
document
hein
schnaitman
matlin
et
al
schlegel
et
al
superti
et
al
thu
vsv
infect
vero
cell
use
posit
control
test
effect
chemic
supplementari
fig
show
vsv
g
protein
express
decreas
nh
cl
treatment
suggest
nh
cl
work
well
confirm
subtox
dose
effect
nh
cl
perform
experi
check
whether
low
ph
depend
ibv
entri
univers
variou
cell
line
increas
ph
cell
mm
nh
cl
pretreat
infect
cell
ibv
bhk
cell
use
experi
posit
control
shown
fig
cell
line
test
viru
intern
significantli
reduc
nh
cl
treatment
dose
depend
manner
compar
h
treat
cell
accordingli
ibv
n
protein
product
significantli
decreas
nh
cl
treatment
taken
togeth
result
demonstr
ibv
entri
requir
low
ph
environ
variou
cell
line
consist
previou
report
chu
et
al
sever
phdepend
endocyt
pathway
use
variou
virus
includ
cme
cavm
macropinocytosi
clathrincaveolinindepend
endocytosi
marsh
heleniu
identifi
endocyt
pathway
employ
ibv
divers
pharmacolog
drug
pretreat
carri
block
variou
endocyt
pathway
effect
ibv
entri
investig
prior
ibv
infect
vero
chicken
cell
expos
increas
concentr
chlorpromazin
cpz
inhibitor
clathrin
coat
pit
format
martinez
et
al
amilorid
tabl
primer
sequenc
plasmid
construct
primer
sequenc
specif
inhibitor
na
h
exchang
activ
import
macropinosom
format
fretz
et
al
kalin
et
al
mercer
heleniu
raghu
et
al
nystatin
well
known
cavm
inhibitor
van
leeuwen
et
al
toxic
inhibitor
care
determin
data
shown
subtox
dose
use
perform
experi
report
vsv
entri
mediat
cme
superti
et
al
thu
vsv
infect
perform
valid
effect
inhibitor
inde
vsv
g
protein
express
inhibit
cpz
amilorid
nystatin
fig
similarli
cme
inhibitor
cpz
significantli
inhibit
intern
ibv
grna
vero
cell
dose
depend
manner
wherea
macropinocytosi
inhibitor
amilorid
chang
intern
ibv
cell
type
fig
accord
ibv
n
protein
express
significantli
inhibit
cpz
amilorid
thu
result
reveal
ibv
enter
cell
via
cme
via
macropinocytosi
least
cell
line
test
involv
cavm
ibv
endocytosi
controversi
cell
lack
function
caveola
beer
et
al
vainio
et
al
effici
viru
intern
replic
observ
fig
indic
ibv
entri
independ
cavm
cell
line
inde
nystatin
pretreat
alter
viru
intern
protein
express
vero
cell
fig
c
thu
least
two
cell
line
ibv
employ
cavm
rout
enter
cell
howev
nystatin
slightli
reduc
ibv
intern
protein
express
cell
especi
concentr
fig
cell
fix
permeabl
stain
dapi
stain
blue
min
room
temperatur
imag
acquir
confoc
laserscan
microscop
zeiss
repres
imag
shown
scale
bar
probabl
cell
addit
cme
cavm
also
hijack
ibv
cell
nystatin
inhibit
viru
intern
realli
reduc
viral
protein
express
fig
underli
mechan
phenomon
unclear
result
conclud
ibv
mainli
employ
cme
enter
cell
howev
cell
line
ibv
may
also
employ
cavm
enter
cell
supplementari
rout
regulatori
protein
character
ubiquit
constitut
associ
protein
adapt
microinject
antibodi
interf
transferrin
egfr
intern
gallo
et
al
suggest
play
import
role
cme
sever
review
describ
previous
express
domin
neg
could
effici
block
uptak
sindbi
viru
panda
et
al
dynamin
gtpase
facilit
membran
fission
gener
endocyt
vesicl
cme
cavm
henley
et
al
smith
et
al
zhu
et
al
mani
review
describ
dynamin
requir
intern
mani
virus
dynamin
domin
neg
mutant
block
viru
entri
cai
et
al
holla
et
al
examin
involv
dynamin
ibv
entri
construct
plasmid
egfpdynamin
egfpdynamin
egfp
tag
nterminu
plasmid
transfect
cell
respect
follow
ibv
infect
express
control
cell
use
experi
due
high
transfect
effici
success
express
egfp
egfpfus
protein
detect
fig
note
express
level
lower
egfpdynamin
compar
egfp
express
cell
express
ibv
n
protein
enhanc
egfpdynamin
express
cell
wherea
reduc
egfpdynamin
express
cell
fig
upper
panel
consist
ibv
intern
progeni
viru
product
significantli
reduc
express
egfpdynamin
fig
low
panel
result
demonstr
import
role
dynamin
ibv
infect
surprisingli
neither
significantli
chang
ibv
intern
protein
express
progeni
viru
releas
compar
egfp
express
cell
fig
seem
involv
ibv
infect
cell
whether
failur
block
ibv
infect
due
low
express
level
unknown
mechan
report
vsv
entri
reli
function
sun
et
al
thu
effect
vsv
entri
vero
cell
examin
control
experi
shown
fig
although
express
level
low
mutant
inde
inhibit
vsv
infect
evidenc
reduc
level
vsv
g
protein
compar
egfp
express
cell
result
suggest
cell
ibv
entri
depend
function
dynamin
probabl
due
ibv
hijack
cme
cavm
enter
cell
evidenc
fig
cme
pathway
block
express
cavm
becom
altern
entri
rout
ibv
anoth
possibl
ibv
entri
depend
cme
requir
help
confirm
conclus
analyz
effect
silenc
dynamin
ibv
uptak
purpos
cell
transfect
nontarget
sirna
sic
sirna
target
either
dynamin
infect
ibv
cell
vsv
vero
cell
control
group
knock
effici
dynamin
uptak
ibv
grna
measur
semiquantit
real
time
rtpcr
shown
fig
b
success
silenc
mrna
obtain
vero
cell
howev
silenc
express
signific
effect
ibv
grna
intern
protein
express
cell
fig
although
deplet
inde
inhibit
vsv
g
express
fig
data
suggest
cme
rout
hamper
vero
bhk
cell
treat
increas
concentr
mm
nh
cl
min
follow
ibv
infect
incom
viru
level
determin
quantif
viral
grna
hpi
viru
n
protein
express
determin
western
blot
analysi
hpi
experi
perform
triplic
averag
valu
stand
error
present
intens
ibv
n
band
determin
imag
j
normal
shown
fold
chang
nh
cl
h
caption
next
page
h
wang
et
al
virolog
deplet
cavm
may
altern
rout
ibv
entri
cell
expect
knock
dynamin
accompani
signific
reduct
amount
incom
ibv
grna
ibv
protein
express
fig
thu
dynamin
function
requir
ibv
entri
cell
due
crucial
role
cme
cavm
analyz
effect
silenc
chc
express
ibv
uptak
cell
transfect
sirna
target
chc
infect
ibv
cell
vsv
vero
cell
control
group
shown
fig
e
deplet
chc
accompani
signific
reduct
ibv
grna
intern
ibvvsv
protein
express
result
suggest
function
cme
pathway
requir
effici
ibv
infect
thu
cme
main
entri
pathway
ibv
saccharomyc
cerevisa
clathrinco
patch
cell
surfac
matur
tubular
invagin
coat
protein
tip
actin
cytoskeleton
machineri
recruit
coat
format
provid
essenti
forc
membran
deform
intern
kaksonen
et
al
recent
studi
reveal
rhabdovirus
regan
whittak
vsv
cureton
et
al
rabv
piccinotti
et
al
ihnv
liu
et
al
intern
cell
via
cme
pathway
actin
filament
involv
although
demonstr
ibv
enter
cell
hijack
clathrin
depend
rout
unclear
whether
actin
filament
involv
ibv
uptak
examin
role
actin
filament
ibv
entri
first
examin
actin
polymer
ibv
intern
vero
cell
incub
ibv
allow
attach
treat
cell
includ
control
remov
unbound
viru
replac
fresh
dmem
temperatur
shift
allow
synchron
intern
actin
filament
stain
alexa
fluor
green
ibv
viru
particl
stain
n
antibodi
red
min
time
interv
shown
fig
mockinfect
cell
actin
stress
fiber
visibl
clearli
number
actin
stress
filament
dramat
decreas
cell
round
cell
surfac
display
signific
bleb
red
arrow
cell
morpholog
actin
distribut
return
normal
vero
cell
pretreat
increas
concentr
cpz
cme
inhibitor
amilorid
macropinocytosi
inhibitor
nystatin
cavm
inhibitor
min
infect
ibv
moi
h
dmso
pretreat
parallel
experi
set
control
incom
viru
level
determin
quantif
viral
grna
hpi
express
level
ibv
n
protein
analyz
hpi
experi
perform
triplic
averag
valu
stand
error
present
panel
c
e
g
e
vero
cell
pretreat
respect
drug
infect
vsv
moi
set
control
express
vsv
g
protein
analyz
western
blot
hpi
intens
ibv
n
vsv
g
band
determin
imag
j
normal
shown
fold
chang
cpz
h
amilorid
dmso
nystatin
dmso
observ
indic
ibv
infect
result
actin
depolymer
rearrang
unfortun
ibv
n
protein
antibodi
fail
detect
incom
viru
make
incom
viru
particl
visibl
appli
vero
cell
decreas
actin
filament
observ
detect
cell
surfac
display
red
signal
white
arrow
enter
cell
associ
filament
shown
yellow
signal
white
arrow
particl
disassoci
actin
filament
display
red
signal
whie
arrow
observ
suggest
ibv
enter
cell
via
actin
cytoskeleton
also
incub
well
character
vero
cell
control
group
ensur
experi
perform
properli
entri
quit
fast
chose
short
time
interv
imag
fig
show
infect
also
caus
actin
filament
depolymer
cell
round
cell
morpholog
actin
distribut
return
normal
meanwhil
associ
actin
fiber
white
arrow
consist
previou
report
mire
et
al
experi
demonstr
ibv
induc
actin
rearrang
move
along
actin
filament
intern
similar
vsv
investig
role
actin
cytoskeleton
ibv
entri
use
chemic
inhibitor
interfer
actin
polymer
depolymer
infect
viru
vero
cell
pretreat
ja
actin
polymerstabil
drug
bubb
et
al
ou
et
al
spector
et
al
cytod
bind
grow
end
actin
filament
prevent
polymer
sampath
pollard
vsv
infect
includ
parallel
experi
control
ensur
inhibitor
work
fig
show
actin
polym
stabil
ja
ibv
intern
increas
dosedepend
manner
upper
panel
consist
express
ibv
n
protein
also
slight
enhanc
middl
panel
fig
show
cytod
prevent
format
actin
polym
ibv
intern
n
protein
express
also
significantli
increas
upper
middl
panel
observ
selfcontradictori
expect
vsv
infect
group
ja
cytod
reduc
vsv
g
protein
express
fig
e
low
panel
consist
previou
report
mire
et
al
result
impli
inhibitor
inde
interfer
actin
polymer
depolymer
report
sfv
infect
also
enhanc
cytod
pretreat
schelhaa
et
al
thu
enhanc
ibv
infect
ja
cytod
case
inhibitor
increas
ibv
entri
underli
mechan
remain
open
question
identif
endocyt
pathway
hijack
ibv
next
track
transport
vesicl
util
incom
ibv
infect
cell
subject
immunostain
use
antibodi
earli
endosom
marker
late
endosom
marker
lysosom
marker
gtpase
requir
movement
endocytos
cargo
earli
late
endosom
feng
et
al
gruenberg
coloc
transport
vesicl
marker
observ
minpi
hpi
shown
fig
red
signal
detect
treat
cell
first
panel
overlap
signal
earli
endosom
marker
mainli
observ
minpi
yellow
dot
white
arrow
second
panel
howev
coimag
hpi
hpi
third
fourth
panel
indic
ibv
enter
earli
endosom
minut
temperatur
shift
dissoci
earli
endosom
hpi
moreov
coloc
viru
particl
mainli
observ
hpi
yellow
dot
white
arrow
third
panel
suggest
enter
late
endosom
hpi
furthermor
found
contain
lysosom
hpi
yellow
dot
white
arrow
fourth
panel
previou
studi
show
vsv
intern
earli
endosom
minut
via
cme
johannsdottir
et
al
ensur
feasibl
reliabl
track
assay
use
infect
immunostain
shown
fig
coloc
well
earli
endosom
marker
minpi
yellow
dot
white
arrow
second
third
fourth
panel
yellow
dot
minpi
fifth
panel
indic
left
earli
endosom
time
point
moreov
almost
coimag
minpi
observ
verifi
vsv
enter
earli
endosom
deliv
late
endosom
lysosom
mire
et
al
demonstr
track
assay
reliabl
altogeth
result
reveal
ibv
enter
earli
endosom
within
minut
endocytosi
pass
late
endosom
around
ac
vero
cell
incub
ibv
h
allow
viru
attach
unbound
viru
particl
wash
away
dmem
mock
infect
infect
set
control
group
temperatur
shift
allow
viru
synchron
intern
cell
fix
indic
time
point
incub
alexa
fluor
green
h
stain
actin
filament
follow
ibv
n
protein
stain
ibv
infect
group
red
nuclei
stain
dapi
blue
signal
observ
confoc
laserscan
microscop
zeiss
repres
imag
shown
scale
bar
red
signal
green
signal
actin
blue
signal
nuclei
cd
vero
cell
pretreat
increas
concentr
cytod
ja
min
infect
ibv
vsv
intern
ibv
grna
assay
hpi
upper
panel
express
ibv
n
protein
middl
panel
vsv
low
panel
determin
hpi
detect
load
control
experi
perform
triplic
averag
valu
stand
error
present
bar
graph
panel
intens
ibv
n
vsv
g
determin
imag
j
normal
shown
fold
chang
ja
dmso
cytod
dmso
caption
next
page
h
wang
et
al
virolog
hpi
reach
lysosom
hpi
ibv
coloc
extens
endolysosom
compart
ask
whether
vehicl
realli
involv
ibv
infecti
rout
achiev
took
advantag
fact
addit
provid
organel
ident
serv
critic
role
regul
cargo
transport
within
endosom
system
accordingli
domin
neg
mutant
gtpbind
defect
mutant
protein
shown
block
cargo
transport
feng
et
al
stenmark
et
al
express
prevent
fusion
endocyt
vesicl
earli
endosom
prevent
cargo
movement
earli
late
endosom
cell
transfect
egfp
fuse
rabswt
rabsdn
rabsca
plasmid
respect
follow
ibv
infect
rabsca
constitut
activ
mutant
constitut
gtpbind
activ
express
enhanc
cargo
transport
abil
endosom
cell
harvest
western
blot
check
express
rab
ibv
n
protein
shown
fig
upper
panel
egfprab
protein
success
express
compar
level
compar
egfp
express
group
express
minim
effect
express
ibv
n
wherea
express
caus
significantli
reduct
ibv
protein
express
fig
upper
panel
accordingli
decreas
intern
ibv
grna
respect
fig
middl
panel
note
express
slightli
increas
viru
intern
fig
middl
panel
data
show
ibv
could
effici
infect
cell
express
indic
transport
earli
late
endosom
necessari
success
infect
ensur
rab
construct
function
examin
effect
rab
vsv
infect
consist
previou
report
mire
et
al
inhibit
vsv
infect
fig
low
panel
collect
data
demonstr
earli
late
endosom
involv
ibv
intracellular
transport
next
knock
carri
confirm
conclus
cell
transfect
follow
ibv
infect
knock
effect
rab
express
ibv
n
protein
examin
western
blot
fig
e
upper
panel
show
express
success
knock
respect
accompani
lower
express
ibv
n
protein
respect
compar
sic
tranfect
cell
quantif
incom
viru
genom
show
knock
significantli
block
viru
intern
fig
middl
fig
incom
transport
along
entir
endocyt
pathway
ab
vero
cell
infect
h
unbound
viru
particl
wash
away
dmem
temperatur
shift
allow
synchron
intern
cell
immunostain
indic
time
point
follow
dapi
stain
infect
includ
parallel
experi
control
signal
observ
confoc
laserscan
microscop
repres
imag
shown
scale
bar
red
signal
green
signal
earli
endosom
later
endosom
lysosom
blue
signal
nuclei
c
cell
transient
transfect
construct
encod
egfp
h
follow
ibv
infect
cell
vsv
infect
vero
cell
express
ibv
n
protein
vsv
g
protein
egfp
detect
correspond
antibodi
hpi
upper
panel
low
panel
incom
viru
level
determin
quantif
viral
grna
hpi
middl
panel
de
cell
transfect
sirna
target
either
respect
nontarget
sirna
sic
transfect
control
h
posttransfect
cell
infect
ibv
cell
vsv
vero
cell
knock
effect
express
ibv
n
vsv
g
detect
western
blot
analysi
hpi
middl
panel
incom
ibv
level
determin
measur
viral
grna
hpi
middl
panel
experi
perform
triplic
averag
valu
stand
error
present
graph
bar
panel
intens
ibv
n
vsv
g
determin
imag
j
normal
shown
fold
chang
rab
sic
sic
h
wang
et
al
virolog
panel
result
demonstr
viru
infect
ineffici
transport
pathway
disabl
remov
ensur
sirab
inde
function
examin
effect
rab
vsv
infect
vero
cell
western
blot
result
show
knock
reduc
vsv
g
protein
express
fig
low
panel
knock
effect
vsv
infect
fig
low
panel
altogeth
data
confirm
earli
late
endosom
requir
intracellular
transport
ibv
dissect
fusion
ibv
envelop
intracellular
vesicl
membran
label
ibv
virion
two
fluoresc
lipid
red
dioc
green
label
method
develop
sakai
cowork
sakai
et
al
intact
viru
membran
display
red
color
high
concentr
quench
fluoresc
signal
emit
dioc
viru
membran
fuse
cellular
membran
two
lipid
dilut
green
fluoresc
dioc
longer
quench
red
green
color
display
respect
rule
possibl
mislabel
cell
debri
membran
cell
cultur
medium
label
dioc
control
vero
cell
infect
diocmock
h
infect
min
h
h
follow
stain
shown
fig
mock
infect
group
neither
red
signal
green
signal
observ
first
panel
infect
cell
minpi
hpi
green
signal
detect
red
color
spot
observ
second
third
panel
moreov
red
spot
coloc
earli
endosom
marker
pink
spot
white
arrow
second
panel
transfer
contain
late
endosom
contain
lysosom
hpi
pink
spot
white
arrow
third
panel
gradual
green
spot
membran
fusion
signal
observ
increas
number
hpi
overlap
either
without
overlap
green
red
spot
white
arrow
fourth
panel
result
impli
ibv
membran
undergo
fusion
late
endosomelysosom
membran
hpi
possibl
fusion
process
may
happen
earlier
time
hpi
hpi
also
perform
fusion
assay
use
report
fuse
earli
endosom
shown
fig
second
panel
pink
spot
overlap
observ
minpi
pink
spot
white
arrow
viru
particl
overlap
time
point
viru
particl
display
red
spot
green
spot
observ
minpi
minpi
fig
third
fourth
panel
green
spot
detect
without
overlap
coloc
well
white
spot
white
arrow
consist
previou
report
mire
et
al
demonstr
ibv
fuse
late
endosomelysosom
hpi
intracellular
traffick
slower
vsv
virus
must
enter
host
cell
start
life
cycl
thu
character
viral
entri
pathway
import
understand
viru
pathogenesi
design
antivir
drug
envelop
virus
penetr
cell
two
differ
way
fusion
cell
plasma
membran
receptormedi
endocytosi
direct
membran
fusion
cell
surfac
independ
low
ph
access
endocytosi
pathway
usual
reli
low
ph
endocyt
vesicl
differ
endocytosi
pathway
character
past
decad
cme
one
commonli
use
mani
envelop
virus
sieczkarski
whittak
coronaviru
entri
mediat
protein
respons
receptor
bind
membran
fusion
previous
demonstr
sarscov
intern
cme
human
hepatoma
cell
line
inou
et
al
howev
cell
entri
sarscov
clathrinand
caveolaeindepend
wang
et
al
mhv
entri
mediat
cme
endolysosom
pathway
proteolysisdepend
manner
burkard
et
al
eifart
et
al
nash
buchmeier
pu
zhang
qiu
et
al
phev
enter
cell
via
cme
cholesterol
low
ph
depend
manner
li
et
al
requir
cme
success
entri
cell
milewska
et
al
cavm
uptak
suggest
nomura
et
al
howev
clinic
isol
bypass
endosom
cell
entri
shirato
et
al
increas
evid
demonstr
coronaviru
entri
mechan
quit
complex
may
enter
cell
via
multipl
pathway
employ
specif
rout
enter
specif
cell
line
differ
viru
strain
serotyp
util
differ
entri
pathway
thu
studi
group
gamma
coronaviru
ibv
entri
mechan
notabl
understand
infect
process
mention
previous
ibv
infect
bhk
cell
inhibit
nh
cl
treatment
chu
et
al
demonstr
ibv
entri
requir
low
ph
trigger
membran
fusion
studi
made
effort
systemat
examin
everi
step
process
first
find
ibv
particl
initi
attach
lipid
raft
plasma
membran
enter
cell
via
cme
requir
help
chc
dynamin
addit
demonstr
ibv
particl
transport
via
earli
late
endosom
fuse
late
endosomelysosom
membran
releas
nucleocapsid
lipid
raft
involv
regul
differ
biolog
event
serv
organ
center
signal
molecul
assembl
influenc
membran
fluiditi
membran
protein
traffick
pike
involv
lipid
raft
viru
entri
assembl
bud
demonstr
either
coloc
studi
viral
structur
protein
lipid
raft
effect
lipid
raft
disrupt
agent
replic
process
sever
virus
suzuki
suzuki
best
character
lipid
raftsrel
nonenvelop
viral
entri
simian
viru
echoviru
type
chazal
gerlier
pietiainen
et
al
bind
mhc
class
receptor
trigger
receptor
cluster
redistribut
caveola
recruit
cytoplasm
site
entri
result
caveolaemedi
endocytosi
min
pietiainen
et
al
cell
type
enter
caveosom
directli
lipid
raft
noncoat
vesicl
rajendran
simon
similar
attach
bind
cell
trigger
cluster
reloc
receptor
lipid
raft
caveolaelik
structur
pietiainen
et
al
deplet
cholesterol
lipid
raft
inhibit
infect
chazal
gerlier
envelop
viru
semliki
forest
viru
sfv
sindbi
viru
sin
requir
cholesterol
sphingolipid
target
membran
lipid
raft
envelop
glycoproteinmedi
membran
fusion
entri
rawat
et
al
mani
envelop
viru
receptor
locat
lipid
raft
would
reloc
lipid
raft
infect
human
tlymphotrop
viru
type
receptor
glucos
transport
ebola
viru
marburg
viru
folat
hepat
b
viru
complement
receptor
type
human
herpesviru
receptor
santoro
et
al
altern
receptor
human
immunodefici
viru
envelop
glycoprotein
epitheli
cell
glycosphingolipid
galactosylceramid
galcer
also
enrich
lipid
raft
alv
et
al
campbel
et
al
membran
cholesterol
also
involv
first
stage
flaviviru
infect
carro
damont
zhu
et
al
guo
et
al
demonstr
ibv
structur
protein
nonstructur
protein
migrat
integr
lipid
raft
viral
protein
translat
cholesterol
enrich
microdomain
involv
ibv
attach
viru
replic
viru
particl
releas
howev
involv
mechan
lipid
raft
ibv
infect
still
unclear
studi
check
involv
lipid
raft
viru
life
cycl
via
disrupt
lipid
raft
use
chemic
pre
postinfect
step
confirm
lipid
raft
involv
viru
entri
step
cholesterol
replenish
experi
confirm
lipid
raft
necessari
ibv
entri
membran
flotat
assay
show
cofraction
ibv
particl
lipid
raft
absorpt
step
valid
immunofluores
experi
display
associ
lipid
raft
cell
surfac
evid
substanti
ibv
initi
entri
step
attach
lipid
raft
experi
show
treatment
chemic
inhibitor
nh
cl
endosom
acidif
variou
suscept
cell
reduc
ibv
intern
protein
express
suggest
low
ph
endosom
requir
ibv
infect
confirm
observ
use
inhibitor
cpz
interfer
cme
variou
suscept
cell
knock
chc
sirna
specif
perturb
cme
cell
found
ibv
intern
protein
vero
cell
infect
h
unbound
viru
particl
wash
away
dmem
temperatur
shift
allow
synchron
intern
indic
time
point
cell
subject
immunostain
use
antibodi
separ
red
dioc
green
signal
coloc
vehicl
marker
blue
observ
confoc
laserscan
microscop
repres
imag
shown
scale
bar
red
signal
green
signal
diocviru
blue
signal
earli
endosom
later
endosom
lysosom
grey
signal
nuclei
express
significantli
decreas
cme
interf
evid
determin
import
cme
ibv
entri
wide
hijack
variou
envelop
virus
moreov
import
dynamin
gtpase
help
snap
vesicl
plasma
membran
determin
ibv
entri
lipid
raft
often
consid
involv
cavm
explain
contradictori
observ
caveolin
defici
cell
line
damm
et
al
vela
et
al
use
cholesterol
deplet
experi
cholesterol
deplet
chemic
cell
similar
inhibit
effect
ibv
entri
observ
vero
cell
result
confirm
although
ibv
attach
entri
depend
intact
lipid
raft
cme
main
endocytot
pathway
intern
cell
cell
nystatin
also
inhibit
ibv
entri
certain
level
suggest
ibv
may
hijack
cavm
altern
entri
rout
two
cell
line
final
research
question
viru
traffick
rout
use
ibv
infect
cell
found
ibv
attach
lead
actin
rearrang
move
along
actin
filament
intern
indic
viru
intern
requir
actin
depolymer
polymer
facilit
viru
contain
vesicl
move
along
actin
filament
howev
stabil
actin
filament
use
ja
inhibit
actin
polymer
use
cytod
result
increas
ibv
entri
remain
open
question
use
viru
stain
endosomallysosom
vesicl
specif
protein
marker
found
intern
incom
ibv
particl
enter
earli
endosom
within
minut
viru
particl
deliv
late
endosom
hpi
final
viru
particl
reach
lysosom
hpi
across
entir
endocyt
network
gtpase
key
regul
cargo
transport
earli
late
endosom
thu
ablat
two
rab
wide
use
studi
viru
entri
import
protein
ibv
entri
examin
overexpress
rna
interfer
technolog
result
show
perturb
earlyl
endosom
transport
overexpress
knock
significantli
reduc
ibv
intern
viral
protein
express
confirm
ibv
traffick
realli
depend
earli
late
endosom
also
use
dioc
doubl
label
viru
reveal
membran
fusion
happen
hpi
time
point
viru
reach
late
endosom
lysosom
specul
ibv
particl
first
transport
earli
endosom
manner
guid
late
endosom
depend
manner
also
depend
indic
membran
fusion
requir
endosom
matur
suggest
low
ph
environ
late
endosom
lysosom
may
provid
import
signal
membran
fusion
ibv
grna
releas
recent
report
show
mhv
infect
also
depend
cme
endosom
matur
late
endosometolysosom
traffick
membran
fusion
requir
cleavag
mhv
protein
lysosom
proteas
introduct
furin
cleavag
site
upstream
fusion
peptid
mhv
protein
render
mhv
independ
lysosom
proteas
fuse
earli
endosom
analysi
upstream
sequenc
fusion
peptid
sever
alpha
beta
gamma
coronavirus
show
merscov
ibvbeaudett
contain
minim
furin
cleavag
site
argxxarg
upstream
fusion
peptid
inde
merscov
infect
requir
furin
mediat
cleavag
lysosom
proteas
requir
traffick
lysosom
effici
entri
sequenc
immedi
upstream
fusion
peptid
protein
might
key
determin
intracellular
site
fusion
cleavag
fusion
proxim
posit
like
gener
requir
coronaviru
entri
burkard
et
al
base
hypothesi
predict
ibvbeaudett
cleav
furin
fuse
earli
endosom
howev
experi
show
ibvbeaudett
particl
requir
traffick
low
ph
environ
late
endosom
lysosom
achiev
membran
fusion
thu
addit
furin
cleavag
yamada
liu
proteas
late
endosom
lysosom
may
involv
ibv
cleavag
time
locat
studi
pesudoviru
bear
sarscov
show
viru
enter
late
endosom
lysosom
minpi
membran
fusion
peak
hpi
mingo
et
al
studi
phev
entri
also
show
procin
coronaviru
move
togeth
endosom
minpi
enter
endolysosom
wide
hpi
li
et
al
therefor
time
intracellular
traffick
fusion
ibvbeaudett
similar
coronavirus
pass
late
endosom
lysosom
conclus
conduct
systemat
studi
dissect
ibv
entri
process
suscept
cell
line
evid
present
indic
ibv
attach
lipid
raft
induc
actin
depolymer
intern
clathrin
coat
vesicl
via
dynamin
snap
transport
fig
model
ibv
intern
traffick
fusion
ibv
attach
lipid
raft
cell
surfac
intern
plasma
membran
via
cme
help
dynamin
actin
depolymer
viru
contain
clathrin
coat
vesicl
taken
earli
endosom
transfer
late
endosom
lysosom
low
ph
environ
late
endosomeslysosom
induc
viruscel
membran
fusion
cpz
nh
cl
target
indic
entri
step
block
viru
entri
along
earlyl
endosom
lysosom
final
fuse
late
endosomelysosom
membran
releas
genom
cytoplasm
fig
understand
cellular
compon
involv
ibv
invas
cell
like
open
new
opportun
develop
novel
therapeut
approach
worth
note
cell
adapt
ibvbeaudett
strain
use
studi
bickerton
et
al
report
three
amino
acid
surround
beaudett
cleavag
site
determin
vero
cell
human
cell
tropism
introduct
beaudetteassoci
amino
acid
suffici
confer
tropism
growth
vero
cell
either
facilit
bind
viru
addit
host
attach
factor
induc
membran
fusion
addit
proteas
cleavag
site
bickerton
et
al
wide
accept
proteas
cleavag
site
protein
determin
coronaviru
entri
fusion
sequenc
differ
protein
variou
ibv
strain
may
determin
cell
tropsim
also
entri
routefus
site
thu
worth
note
studi
may
reflect
situat
field
strain
ibv
primari
cell
tissu
bird
